Chemoinformaics analysis of 1-Stearoyl-2-linoleoyl-sn-glycero-3-phosphatidylcholine
| Molecular Weight | 786.129 | nRot | 40 |
| Heavy Atom Molecular Weight | 701.457 | nRig | 5 |
| Exact Molecular Weight | 785.593 | nRing | 0 |
| Solubility: LogS | -2.673 | nHRing | 0 |
| Solubility: LogP | 8.175 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 138 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 54 | No. of Aromatic Carbocycles | 0 |
| nHetero | 10 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 84 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 44 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 8 | No. of Arom Bond | 0 |
| nHA | 8 | APOL | 140.637 |
| nHD | 0 | BPOL | 104.805 |
| QED | 0.02 |
| Synth | 4.277 |
| Natural Product Likeliness | 0.731 |
| NR-PPAR-gamma | 0.137 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.891 |
| HIA | 0.96 |
| CACO-2 | -5.265 |
| MDCK | 0.0000186 |
| BBB | 0 |
| PPB | 1.01814 |
| VDSS | 0.167 |
| FU | 0.0054314 |
| CYP1A2-inh | 0.027 |
| CYP1A2-sub | 0.459 |
| CYP2c19-inh | 0.225 |
| CYP2c19-sub | 0.073 |
| CYP2c9-inh | 0.102 |
| CYP2c9-sub | 0.994 |
| CYP2d6-inh | 0.394 |
| CYP2d6-sub | 0.865 |
| CYP3a4-inh | 0.664 |
| CYP3a4-sub | 0.016 |
| CL | 3.148 |
| T12 | 0.896 |
| hERG | 0.722 |
| Ames | 0.743 |
| ROA | 0.036 |
| SkinSen | 0.97 |
| Carcinogencity | 0.11 |
| EI | 0.011 |
| Respiratory | 0.662 |
| NR-Aromatase | 0.905 |
| Antiviral | Yes |
| Prediction | 0.807307 |